Internal Medicine, General Medicine Conference-IPSC 2026

Cardiometabolic medicine spans the specialties of cardiology, endocrinology, and internal medicine to treat comorbidities like obesity, diabetes, and hypertension. Internists are key figures in the diagnosis, treatment, and prevention of cardiometabolic syndrome, which strongly predicts cardiovascular risk.

Recent developments encompass GLP-1 receptor agonists, SGLT2 inhibitors, and new lipid-lowering therapies that enhance outcomes and decrease long-term complications. By encouraging lifestyle interventions in addition to pharmacological developments, internists enable patients to cope with multifaceted comorbidities. This integrated approach makes cardiometabolic health a priority in contemporary internal medicine.